Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine

The metabolic and molecular bases of inherited disease

Ying-Tsong Chen · Medical Entomology and Zoology · 2001 · 6.9K citations

Life Sciences, Genetics, Molecular Genetics +14

Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary

Michael S. Watson, Marie Y. Mann, Michele A. Lloyd-Puryear et al. · PEDIATRICS · 2006 · 501 citations

Medicine, Genetics, Pediatrics +17

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

David McHugh, Cynthia A. Cameron, José E. Abdenur et al. · Genetics in Medicine · 2011 · 352 citations · Full text

Medicine, Biochemistry, Mass Spectrometric Analysis +16

Reduction of the false‐positive rate in newborn screening by implementation of MS/MS‐based second‐tier tests: The Mayo Clinic experience (2004–2007)

Dietrich Matern, Silvia Tortorelli, Devin Oglesbee et al. · Journal of Inherited Metabolic Disease · 2007 · 222 citations · Full text

Medicine, Pediatrics, Preventive Medicine +12

NTBC treatment in tyrosinaemia type I: Long‐term outcome in French patients

Alice Masurel‐Paulet, Joséphine Poggi-Bach, M. O. Rolland et al. · Journal of Inherited Metabolic Disease · 2008 · 216 citations

Medicine, Hematology, Immunology +2